Dr. Christian Schneider,
Director of the National Institute for Biological Standards and Control (NIBSC) in the UK
Part 2: First-in-human clinical studies with biotechnology-derived medicines
Start: 12.00 a.m. s.t.
Video lecture via Zoom:
Meeting-ID: 853 1599 7528
Identification code: 458438
Further lecture dates in 2020:
10.11.2020: Part 3 - Non-clinical development of gene and cell therapies as a paradigm of translational research
09.12.2020: Part 4 - Risk-based approaches in translational medicine